HK1212683A1 - 多個激酶途徑抑制劑 - Google Patents

多個激酶途徑抑制劑

Info

Publication number
HK1212683A1
HK1212683A1 HK16100505.0A HK16100505A HK1212683A1 HK 1212683 A1 HK1212683 A1 HK 1212683A1 HK 16100505 A HK16100505 A HK 16100505A HK 1212683 A1 HK1212683 A1 HK 1212683A1
Authority
HK
Hong Kong
Prior art keywords
pathway inhibitors
kinase pathway
multiple kinase
inhibitors
pathway
Prior art date
Application number
HK16100505.0A
Other languages
English (en)
Inventor
Qingping Zeng
Mary Faris
Alexis Mollard
Steven L Warner
Gary A Flynn
Original Assignee
Mannkind Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mannkind Corp filed Critical Mannkind Corp
Publication of HK1212683A1 publication Critical patent/HK1212683A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
HK16100505.0A 2012-09-26 2016-01-18 多個激酶途徑抑制劑 HK1212683A1 (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261706084P 2012-09-26 2012-09-26
US201361757331P 2013-01-28 2013-01-28
US201361785992P 2013-03-14 2013-03-14
PCT/US2013/061548 WO2014052365A1 (en) 2012-09-26 2013-09-25 Multiple kinase pathway inhibitors

Publications (1)

Publication Number Publication Date
HK1212683A1 true HK1212683A1 (zh) 2016-06-17

Family

ID=50388917

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16100505.0A HK1212683A1 (zh) 2012-09-26 2016-01-18 多個激酶途徑抑制劑

Country Status (8)

Country Link
US (2) US9493454B2 (zh)
EP (1) EP2900668A4 (zh)
JP (1) JP2015532281A (zh)
CN (1) CN104812756A (zh)
AU (1) AU2013323736A1 (zh)
CA (1) CA2886275A1 (zh)
HK (1) HK1212683A1 (zh)
WO (1) WO2014052365A1 (zh)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE052198T2 (hu) 2011-07-21 2021-04-28 Sumitomo Dainippon Pharma Oncology Inc Heterociklusos protein kináz inhibitorok
JP2015532281A (ja) * 2012-09-26 2015-11-09 マンカインド コーポレイション 複数キナーゼ経路阻害剤
KR102334260B1 (ko) 2013-03-14 2021-12-02 스미토모 다이니폰 파마 온콜로지, 인크. Ｊａｋ2 및 ａｌｋ2 억제제 및 이들의 사용 방법
CN104418853B (zh) * 2013-08-28 2016-09-07 北大方正集团有限公司 取代的萘啶-2-酮化合物、制备方法、用途及药物组合物
CN105622638B (zh) * 2014-10-29 2018-10-02 广州必贝特医药技术有限公司 嘧啶或吡啶并吡啶酮类化合物及其制备方法和应用
WO2016161248A1 (en) * 2015-04-02 2016-10-06 Tolero Pharmaceuticals, Inc. Targeting pim kinases in combination with btk inhibition
EP3331510A4 (en) 2015-08-03 2019-04-03 Tolero Pharmaceuticals, Inc. COMBINATORIAL THERAPIES FOR THE TREATMENT OF CANCER
CN105130986B (zh) * 2015-09-30 2017-07-18 广州科擎新药开发有限公司 嘧啶或吡啶并吡啶酮类化合物及其应用
WO2018094275A1 (en) 2016-11-18 2018-05-24 Tolero Pharmaceuticals, Inc. Alvocidib prodrugs and their use as protein kinase inhibitors
KR102513448B1 (ko) * 2016-12-16 2023-03-23 씨스톤 파마슈티컬즈 Cdk4/6 억제제
CN108264511B (zh) * 2017-01-03 2021-04-13 浙江海正药业股份有限公司 杂环类衍生物及其制备方法和其在医药上的用途
US11174255B2 (en) * 2017-05-15 2021-11-16 University Of Houston System Pyrido[2,3-d]pyrimidin-7-ones and related compounds as inhibitors of protein kinases
US11497756B2 (en) 2017-09-12 2022-11-15 Sumitomo Pharma Oncology, Inc. Treatment regimen for cancers that are insensitive to BCL-2 inhibitors using the MCL-1 inhibitor alvocidib
BR112020020246A8 (pt) 2018-04-05 2022-10-18 Sumitomo Dainippon Pharma Oncology Inc Inibidores de cinase axl e uso dos mesmos
EP3773560A4 (en) 2018-04-13 2022-01-19 Sumitomo Dainippon Pharma Oncology, Inc. PIM KINASE INHIBITORS FOR THE TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS AND CANCER-ASSOCIATED FIBROSIS
KR20210038906A (ko) 2018-07-26 2021-04-08 스미토모 다이니폰 파마 온콜로지, 인크. 비정상적 acvr1 발현과 연관된 질환을 치료하는 방법 및 그에 사용하기 위한 acvr1 억제제
CN113490499A (zh) 2018-12-04 2021-10-08 大日本住友制药肿瘤公司 用作治疗癌症的活性剂的cdk9抑制剂及其多晶型物
MX2021005075A (es) * 2018-12-07 2021-07-15 Sumitomo Pharma Oncology Inc Metodos para el tratamiento de cancer de prostata resistente a la castracion y sensible a la castracion.
JP2022520361A (ja) 2019-02-12 2022-03-30 スミトモ ダイニッポン ファーマ オンコロジー， インコーポレイテッド 複素環式タンパク質キナーゼ阻害剤を含む製剤
WO2020191326A1 (en) 2019-03-20 2020-09-24 Sumitomo Dainippon Pharma Oncology, Inc. Treatment of acute myeloid leukemia (aml) with venetoclax failure
CN117430597A (zh) * 2022-07-14 2024-01-23 浙江同源康医药股份有限公司 用作cdk4激酶抑制剂的化合物及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL117923A (en) 1995-05-03 2000-06-01 Warner Lambert Co Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds
US5945422A (en) 1997-02-05 1999-08-31 Warner-Lambert Company N-oxides of amino containing pyrido 2,3-D! pyrimidines
NZ502704A (en) * 1997-08-20 2002-06-28 Warner Lambert Co Naphthyridinones and pharmaceuticals thereof and their use in inhibiting cellular proliferation and protein tyrosine kinase or cell cycle kinase enzymatic activity
US6303652B1 (en) * 1998-08-21 2001-10-16 Hughes Institute BTK inhibitors and methods for their identification and use
WO2004065378A1 (en) * 2003-01-17 2004-08-05 Warner-Lambert Company Llc 2-aminopyridine substituted heterocycles as inhibitors of cellular proliferation
US7449582B2 (en) * 2003-10-08 2008-11-11 Irm Llc Compounds and compositions as protein kinase inhibitors
BRPI0711628A2 (pt) * 2006-05-15 2011-12-06 Irm Llc composto, composição farmacêutica, uso e processo para preparação do composto
MX2008014450A (es) 2006-05-18 2009-03-09 Mannkind Corp Inhibidores de cinasa intracelular.
JP2015532281A (ja) * 2012-09-26 2015-11-09 マンカインド コーポレイション 複数キナーゼ経路阻害剤

Also Published As

Publication number Publication date
JP2015532281A (ja) 2015-11-09
US20170107215A1 (en) 2017-04-20
AU2013323736A8 (en) 2015-04-30
CN104812756A (zh) 2015-07-29
EP2900668A1 (en) 2015-08-05
US20150266870A1 (en) 2015-09-24
US9493454B2 (en) 2016-11-15
EP2900668A4 (en) 2016-04-20
WO2014052365A1 (en) 2014-04-03
US9714247B2 (en) 2017-07-25
CA2886275A1 (en) 2014-04-03
AU2013323736A1 (en) 2015-04-09

Similar Documents

Publication Publication Date Title
HK1212683A1 (zh) 多個激酶途徑抑制劑
HK1210775A1 (zh) 作為激酶抑制劑的咪唑並三嗪甲腈
HK1208442A1 (zh) 作為 激酶抑制劑的取代的吡咯並嘧啶基氨基－苯並噻唑酮
HK1222647A1 (zh) 激酶抑制劑
HK1215577A1 (zh) 蛋白激酶抑制劑
HUE048834T2 (hu) Kináz inhibitorok
LT2903618T (lt) Rho kinazės inhibitoriai
EP2917210A4 (en) KINASE INHIBITORS
IL229028A0 (en) Kinase inhibitors
HK1199873A1 (zh) 激酶抑制劑
PL2634185T3 (pl) Inhibitory kinazy TYK2
HK1209726A1 (zh) 蛋白激酶抑制劑
HK1205507A1 (zh) 蛋白激酶抑制劑
SG11201500973WA (en) Amino-quinolines as kinase inhibitors
HK1213252A1 (zh) 雙環二氫吡啶酮激酶抑制劑
HK1208460A1 (zh) 蛋白激酶抑制劑
HK1213181A1 (zh) 雙環氧雜內酰胺激酶抑制劑